Envestnet Asset Management
ONC

Envestnet Asset Management’s BeOne Medicines Ltd ONC Stock Holding History

Envestnet Asset Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.2M Buy
60,525
+914
+2% +$269K ﹤0.01% 1553
2026
Q1 		$17.7M Buy
59,611
+3,245
+6% +$1.05M ﹤0.01% 1423
2025
Q4 		$17.1M Sell
56,366
-6,886
-11% -$2.25M 0.01% 1311
2025
Q3 		$21.6M Buy
63,252
+1,032
+2% +$313K 0.01% 1228
2025
Q2 		$15.1M Buy
62,220
+1,092
+2% +$268K ﹤0.01% 1442
2025
Q1 		$16.6M Sell
61,128
-1,014
-2% -$237K 0.01% 1322
2024
Q4 		$11.5M Buy
62,142
+5,560
+10% +$1.14M ﹤0.01% 1545
2024
Q3 		$12.7M Sell
56,582
-6,558
-10% -$1.18M ﹤0.01% 1467
2024
Q2 		$9.01M Sell
63,140
-1,646
-3% -$254K ﹤0.01% 1627
2024
Q1 		$10.1M Buy
64,786
+15,421
+31% +$2.48M ﹤0.01% 1519
2023
Q4 		$8.9M Buy
49,365
+2,683
+6% +$485K ﹤0.01% 1525
2023
Q3 		$8.4M Buy
46,682
+16,295
+54% +$3.22M ﹤0.01% 1484
2023
Q2 		$5.42M Sell
30,387
-1,647
-5% -$379K ﹤0.01% 1660
2023
Q1 		$6.9M Buy
32,034
+3,250
+11% +$780K ﹤0.01% 1471
2022
Q4 		$6.33M Buy
28,784
+4,050
+16% +$743K ﹤0.01% 1466
2022
Q3 		$3.33M Sell
24,734
-93
-0.4% -$16K ﹤0.01% 1759
2022
Q2 		$4.02M Buy
24,827
+764
+3% +$119K ﹤0.01% 1647
2022
Q1 		$4.54M Buy
24,063
+1,492
+7% +$317K ﹤0.01% 1661
2021
Q4 		$6.12M Buy
22,571
+533
+2% +$180K ﹤0.01% 1484
2021
Q3 		$8M Buy
22,038
+2,079
+10% +$680K ﹤0.01% 1263
2021
Q2 		$6.85M Buy
19,959
+2,575
+15% +$853K ﹤0.01% 1335
2021
Q1 		$6.05M Buy
17,384
+4,358
+33% +$1.44M ﹤0.01% 1322
2020
Q4 		$3.37M Buy
13,026
+2,297
+21% +$632K ﹤0.01% 1469
2020
Q3 		$3.07M Buy
10,729
+1,976
+23% +$464K ﹤0.01% 1384
2020
Q2 		$1.65M Buy
8,753
+601
+7% +$97.8K ﹤0.01% 1686
2020
Q1 		$1M Sell
8,152
-286
-3% -$44.7K ﹤0.01% 1820
2019
Q4 		$1.4M Buy
8,438
+1,490
+21% +$248K ﹤0.01% 1812
2019
Q3 		$851K Sell
6,948
-51
-0.7% -$6.77K ﹤0.01% 2051
2019
Q2 		$868K Buy
6,999
+417
+6% +$52.9K ﹤0.01% 2050
2019
Q1 		$869K Buy
6,582
+1,551
+31% +$209K ﹤0.01% 1987
2018
Q4 		$706K Buy
+5,031
New +$667K ﹤0.01% 1939

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Envestnet Asset Management's ONC Position: Q2 2026 in Review

Envestnet Asset Management increased its BeOne Medicines Ltd (ONC) stake by 1.5% in Q2 2026, buying an estimated $269K and bringing the position to 60,525 shares worth $17.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1553.

Envestnet Asset Management first reported a position in ONC in Q4 2018 and has held it in 31 quarters since. The position peaked at $21.6M in Q3 2025. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Envestnet Asset Management held 60,525 shares of BeOne Medicines Ltd worth $17.2M as of Q2 2026.
  • Envestnet Asset Management bought 914 BeOne Medicines Ltd shares in Q2 2026, an estimated $269K.
  • BeOne Medicines Ltd made up ﹤0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #1553 holding.
  • Envestnet Asset Management first reported a position in BeOne Medicines Ltd in Q4 2018 and has held it in 31 quarters since.
  • Envestnet Asset Management's BeOne Medicines Ltd position peaked at $21.6M in Q3 2025.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.